Abstract:In addition to the cleavages that generate Aß, APP is processed at Asp664 in its intracellular domain, releasing a second toxic peptide, APP-C31 [Nat Med 6:397;Cell 97:395]. Transgenic mice otherwise identical to a well-characterized model of AD, PDAPP mice, but carrying a mutation that obliterates Asp664, do not display AD-like cognitive deficits, nor alterations in non-cognitive components of behavior, in spite of accumulating very high levels of Aß [PNAS 103:7130;JNeurosci 26:13428;Behav Brain Res 191:246]. These results suggest that cleavage of APP at Asp664 plays a role in the generation of AD-like deficits, and that a major pathway of Aß-induced toxicity in vivo, or a pathway that crucially impinges on it, may depend on the cleavage of APP at Asp664. Young PDAPP(D664A) mice, however, show a pronounced kinetic phenotype akin to the tonic phase of a seizure (immobility in stereotyped limb positions) when first exposed to swimming. To rule out confounding effects (e.g., mistaken scoring as floating and increased latencies) in MWM studies, a cohort was trained-to-criterion (normal swimming) (3 months) and pre-exposed to the Morris water maze (MWM) environment (5 months), then compared to a cohort without prior experience. Objective: Determine whether swimming training-to-criterion and preexposure to MWM (“practice”) affects cognitive and non-cognitive components of performance in PDAPP and PDAPP(D664A) mice. Learning impairments were found in PDAPP mice irrespective of prior experience. In contrast, while no learning impairments were present in practiced PDAPP(D664A) mice, non-practiced PDAPP(D664A) mice showed an intermediate phenotype, with performance indistinguishable from non-Tg littermates' but also indistinguishable from that of PDAPP mice. Floating (helplessness) decreased across trials for all practiced but increased for all non-practiced groups, and only practiced PDAPP mice showed increased floating. No differences in thigmotactic swim (anxiety) were observed among non-practiced groups. Practiced PDAPP mice, however, showed increased thigmotaxis, while practiced PDAPP(D664A) mice were indistinguishable from non-Tg littermates. Our results indicate that swimming training-to-criterion and preexposure to MWW do not affect learning impairments in PDAPP mice, but may contribute to improved performance of PDAPP(D664A) animals, suggesting that these early experiences may be required for the complete amelioration of learning deficits in PDAPP(D664A) mice.

Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.

Reversal of Learning Deficits in Happ Transgenic Mice Carrying a Mutation at Asp664: A Role for Early Experience

Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Early Disruption of Synaptic Function, Impairment of Plasticity, and Decreased of Cortical Circuit Connectivity in an Alzheimer’S Mouse Model of Amyloid Deposition

Impaired Synaptic Plasticity and Learning in Aged Amyloid Precursor Protein Transgenic Mice.

Gene deletion of Pregnancy-associated Plasma Protein-A (PAPP-A) improves pathology and cognition in an Alzheimer's disease mouse model

P2‐359: Cathepsin B Gene Deletion or Inhibition Improves Memory Deficits in a Mouse Model of Alzheimer's Disease Expressing APP with the Wild‐type Beta‐secretase Site

P4‐022: Swimming Training‐to‐criterion and Pre‐exposure to MWM Are Required for Complete Restoration of Learning in APP Transgenic Mice Carrying a Mutation in Asp664

Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: Deficit in memory retrieval associated with increased sensitivity to interference?

Dual-Specificity Protein Phosphatase 4 (DUSP4) Overexpression Improves Learning Behavior Selectively in Female 5xfad Mice, and Reduces Β-Amyloid Load in Males and Females

Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.

Memory impairments in Tg19959 and APP/PS1 AD model mice are alleviated by eEF2K inhibitor A‐484954

Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease

A Learning Deficit Related to Age and Β-Amyloid Plaques in a Mouse Model of Alzheimer's Disease

A Learning Deficit Related To Age And Beta-Amyloid Plaques In A Mouse Model Of Alzheimer'S Disease

Altered brain arginine metabolism with age in the APPswe/PSEN1dE9 mouse model of Alzheimer's disease

Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer’s Mouse Model of Amyloid Deposition

Β-Amyloid Accumulation Enhances Microtubule Associated Protein Tau Pathology in an APPNL-G-F/MAPTP301S Mouse Model of Alzheimer’s Disease

Early Inhibition of Phosphodiesterase 4B (PDE4B) Instills Cognitive Resilience in APPswe/PS1dE9 Mice

Active Beta-Amyloid Immunization Restores Spatial Learning in Pdapp Mice Displaying Very Low Levels of Beta-Amyloid

Progressive Spatial Memory Impairment, Brain Amyloid Deposition And Changes In Serum Amyloid Levels As A Function Of Age In Appswe/Ps1de9 Mice